Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 17 | $5,499,522 |
| Sells | 19 | $5,991,551 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Sep 2024 20:05 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 16 Sep 2024 | Sale | 30,000 | 12.97 | 389,100 | I |
| 17 Sep 2024 20:05 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 13 Sep 2024 | Sale | 65,000 | 13.47 | 875,550 | I |
| 30 Aug 2024 16:15 | YMAB | Y-mAbs Therapeutics Inc | LUND-HANSEN TORBEN | SVP & CHIEF TECHNICAL OFFICER | 28 Aug 2024 | Sale | 50,000 | 15.37 | 768,500 | D |
| 27 Aug 2024 17:05 | YMAB | Y-mAbs Therapeutics Inc | WILMS JORIS | SVP & CHIEF OPERATING OFFICER | 26 Aug 2024 | Sale | 5,000 | 14.69 | 73,450 | D |
| 11 Jun 2024 19:53 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 11 Jun 2024 | Sale | 35,000 | 12 | 420,000 | I |
| 11 Jun 2024 19:53 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 10 Jun 2024 | Sale | 35,000 | 12.03 | 421,050 | I |
| 11 Jun 2024 19:54 | YMAB | Y-mAbs Therapeutics Inc | BER GERARD | Director | 10 Jun 2024 | Sale | 722 | 12 | 8,664 | D |
| 31 May 2024 21:36 | YMAB | Y-mAbs Therapeutics Inc | KRUSE BO | EVP, CFO, SECRY & TREAS. | 31 May 2024 | Sale | 31,371 | 12.07 | 378,648 | D |
| 31 May 2024 21:36 | YMAB | Y-mAbs Therapeutics Inc | KRUSE BO | EVP, CFO, SECRY & TREAS. | 30 May 2024 | Sale | 28,629 | 12.03 | 344,407 | D |
| 23 May 2024 18:54 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 23 May 2024 | Sale | 7,351 | 13 | 95,563 | I |
| 23 May 2024 18:54 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 21 May 2024 | Sale | 25,000 | 12 | 300,000 | I |
| 07 Mar 2024 16:59 | YMAB | Y-mAbs Therapeutics Inc | SMITH SUSAN LAURA | SVP & CHIEF COMMERCIAL OFFICER | 05 Mar 2024 | Sale | 1,682 | 16.55 | 27,837 | D |
| 07 Mar 2024 17:01 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | CHIEF BUSINESS OFFICER | 05 Mar 2024 | Sale | 3,900 | 16.44 | 64,116 | D |
| 07 Mar 2024 17:02 | YMAB | Y-mAbs Therapeutics Inc | RAJAH VIGNESH | SVP & CHIEF MEDICAL OFFICER | 05 Mar 2024 | Sale | 1,711 | 16.53 | 28,283 | D |
| 15 Dec 2023 19:40 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | Chief Business Officer | 15 Dec 2023 | Sale | 50,000 | 6.61 | 330,500 | I |
| 15 Dec 2023 19:40 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | Chief Business Officer | 14 Dec 2023 | Sale | 50,000 | 6.83 | 341,500 | I |
| 15 Dec 2023 19:40 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | Chief Business Officer | 13 Dec 2023 | Sale | 50,000 | 6.58 | 329,000 | I |
| 12 Dec 2023 08:26 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 11 Dec 2023 | Purchase | 6,455 | 6.8523 | 44,232 | I |
| 12 Dec 2023 08:27 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 11 Dec 2023 | Purchase | 6,455 | 6.8523 | 44,232 | D |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 11 Dec 2023 | Purchase | 102,863 | 7.0078 | 720,843 | I |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 11 Dec 2023 | Purchase | 102,863 | 7.0078 | 720,843 | D |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 08 Dec 2023 | Purchase | 18,503 | 6.9923 | 129,379 | I |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 08 Dec 2023 | Purchase | 18,503 | 6.9923 | 129,379 | D |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 07 Dec 2023 | Purchase | 6,183 | 6.5 | 40,190 | I |
| 11 Dec 2023 17:25 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 07 Dec 2023 | Purchase | 6,183 | 6.5 | 40,190 | D |
| 01 Dec 2023 17:14 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 29 Nov 2023 | Purchase | 51,837 | 5.9702 | 309,477 | I |
| 01 Dec 2023 17:15 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 29 Nov 2023 | Purchase | 51,837 | 5.9702 | 309,477 | D |
| 29 Nov 2023 17:15 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 28 Nov 2023 | Purchase | 30,671 | 5.8125 | 178,275 | I |
| 29 Nov 2023 17:14 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 28 Nov 2023 | Purchase | 30,671 | 5.8125 | 178,275 | D |
| 29 Nov 2023 17:15 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 27 Nov 2023 | Purchase | 62,516 | 5.4869 | 343,019 | I |
| 29 Nov 2023 17:14 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 27 Nov 2023 | Purchase | 62,516 | 5.4869 | 343,019 | D |
| 22 Nov 2023 17:00 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | Chief Business Officer | 21 Nov 2023 | Sale | 75,000 | 5.3065 | 397,988 | I |
| 22 Nov 2023 17:00 | YMAB | Y-mAbs Therapeutics Inc | GAD THOMAS | Chief Business Officer | 20 Nov 2023 | Sale | 75,000 | 5.2986 | 397,395 | I |
| 17 May 2023 17:05 | YMAB | Y-mAbs Therapeutics Inc | WG BIOTECH APS | Director | 15 May 2023 | Purchase | 101,740 | 9.6462 | 981,404 | D |
| 17 May 2023 17:07 | YMAB | Y-mAbs Therapeutics Inc | WEDELL-WEDELLSBORG JOHAN | Director | 15 May 2023 | Purchase | 101,740 | 9.6462 | 981,404 | I |
| 16 Nov 2022 19:01 | YMAB | Y-mAbs Therapeutics Inc | RAJAH VIGNESH | SVP & CMO | 15 Nov 2022 | Purchase | 1,195 | 4.924 | 5,884 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)